Lonaprisan Uses, Dosage, Side Effects and more
Lonaprisan is under investigation in clinical trial NCT00555919 (ZK 230211 in Postmenopausal Woman With Metastatic Breast Cancer).
| Trade Name | Lonaprisan |
| Generic | Lonaprisan |
| Lonaprisan Other Names | Lonaprisan |
| Type | |
| Formula | C28H29F5O3 |
| Weight | Average: 508.529 Monoisotopic: 508.203685609 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
